BCR kinase phosphorylates 14-3-3 Tau on residue 233

FEBS Journal

Volumn 272, Issue 15, 2005, Pages 3767-3776

  Clokie, Samuel J ^a   Cheung, Kin Y ^a   Mackie, Shaun ^a,c   Marquez, Rodolfo ^b   Peden, Alex H ^a,d   Aitken, Alastair ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

14 3 3 isoforms; BCR kinase; Phosphorylation; Protein interactions

Indexed keywords

BCR ABL PROTEIN; CASEIN KINASE I; ISOPROTEIN; PROTEIN 14 3 3; PROTEIN BAX; RAF PROTEIN; SERINE; TAU PROTEIN; THREONINE; TYROSINE;

ARTICLE; BINDING SITE; CELL STRAIN HEK293; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DIMERIZATION; DRUG PROTEIN BINDING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR GENETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

14-3-3 PROTEINS; AMINO ACID SUBSTITUTION; ANIMALS; CASEIN KINASE I; CELL LINE, TRANSFORMED; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; ISOENZYMES; MUTATION; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCR;

EID: 23644457605     PISSN: 1742464X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04765.x     Document Type: Article

References (54)

1. Laurent E, Talpaz M, Kantarjian H & Kurzrock R (2001) The BCR gene and Philadelphia chromosome-positive leukemogenesis. Cancer Res 61, 2343-2355.
2. Nowell PC & Hungerford DA (1960) Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 25, 85-109.
3. Li WJ, Dreazen O, Kloetzer W, Gale RP & Arlinghaus RB (1989) Characterization of bcr gene products in hematopoietic cells. Oncogene 4, 127-138.
4. McLaughlin J, Chianese E & Witte ON (1989) Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells. Mol Cell Biol 9, 1866-1874.
5. Lugo TG, Pendergast AM, Muller AJ & Witte ON (1990) Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247, 1079-1082.
6. Salesse S & Verfaillie CM (2002) BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia. Oncogene 21, 8547-8559.
7. McWhirter JR, Galasso DL & Wang JY (1993) A coiled-coil oligomerization domain of BCR is essential for the transforming function of BCR-Abl oncoproteins. Mol Cell Biol 13, 7587-7595.
8. Maru Y & Witte ON (1991) The BCR gene encodes a novel serine/threonine kinase activity within a single exon. Cell 67, 459-468.
9. Reuther GW, Fu H, Cripe LD, Collier RJ & Pendergast AM (1994) Association of the protein kinases c-BCR and BCR-Abl with proteins of the 14-3-3 family. Science 266, 129-133.
10. Braselmann S & McCormick F (1995) BCR and Raf form a complex in vivo via 14-3-3 proteins. EMBO J 14, 4839-4848.
11. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Der Rabun KMCJ, Schlessinger J et al. (1993) BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75, 175-185.
12. Adams JM, Houston H, Allen J, Lints T & Harvey R (1992) The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene 7, 611-618.
13. Ron D, Zannini M, Lewis M, Wickner RB, Hunt LT, Graziani G, Tronick SR, Aaronson SA & Eva A (1991) A region of proto-dbl essential for its transforming activity shows sequence similarity to a yeast cell cycle gene, CDC24, and the human breakpoint cluster gene, bcr. New Biol 3, 372-379.
14. Diekmann D, Brill S, Garrett MD, Totty N, Hsuan J, Monfries C, Hall C, Lim L & Hall A (1991) BCR encodes a GTPase-activating protein for p21rac. Nature 351, 400-402.
15. Takeda N, Shibuya M & Maru Y (1999) The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein. Proc Natl Acad Sci USA 96, 203-207.
16. Wetzler M, Talpaz M, Yee G, Stass SA, Van Etten RA, Andreeff M, Goodacre AM, Kleine HD, Mahadevia RK & Kurzrock R (1995) Cell cycle-related shifts in subcellular localization of BCR: association with mitotic chromosomes and with heterochromatin. Proc Natl Acad Sci USA 92, 3488-3492.
17. Boisguerin P, Leben R, Ay B, Radziwill G, Moelling K, Dong L & Volkmer-Engert R (2004) An improved method for the synthesis of cellulose membrane-bound peptides with free C termini is useful for PDZ domain binding studies. Chem Biol 11, 449-459.
18. Fu H, Subramanian RR & Masters SC (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40, 617-647.
19. Aitken A (2002) Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants. Plant Mol Biol 50, 993-1010.
20. MacKintosh C (2004) Dynamic interactions between 14 and 3-3s and phosphoproteins regulate diverse cellular processes. Biochem J 381, 329-342.
21. Muslin AJ, Tanner JW, Allen PM & Shaw AS (1996) Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84, 889-897.
22. Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, Gamblin SJ, Smerdon SJ & Cantley LC (1997) The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 91, 961-971.
23. Xiao B, Smerdon SJ, Jones DH, Dodson GG, Soneji Y, Aitken A & Gamblin SJ (1995) Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 376, 188-191.
24. Liu D, Bienkowska J, Petosa C, Collier RJ, Fu H & Liddington R (1995) Crystal structure of the zeta isoform of the 14-3-3 protein. Nature 376, 191-194.
25. Henriksson ML, Francis MS, Peden A, Aili M, Stefansson K, Palmer R, Aitken A & Hallberg B (2002) A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. Eur J Biochem 269, 4921-4929.
26. Tzivion G & Avruch J (2002) 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem 277, 3061-3064.
27. Aitken A (1996) 14-3-3 and its possible role in coordinating multiple signalling pathways. Trends Cell Biol 6, 341-347.
28. Rommel C, Radziwill G, Lovric J, Noeldeke J, Heinicke T, Jones D, Aitken A & Moelling K (1996) Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1. Oncogene 12, 609-619.
29. Bonnefoy-Berard N, Liu YC, von Willebrand M, Sung A, Elly C, Mustelin T, Yoshida H, Ishizaka K & Altman A (1995) Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. Proc Natl Acad Sci USA 92, 10142-10146.
30. Aitken A, Howell S, Jones D, Madrazo J & Patel Y (1995) 14-3-3 alpha and delta are the phosphorylated forms of raf-activating 14-3-3 beta and zeta. In vivo stoichiometric phosphorylation in brain at a Ser-Pro-Glu-Lys MOTIF. J Biol Chem 270, 5706-5709.
31. Gross SD & Anderson RA (1998) Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family. Cell Signal 10, 699-711.
32. Vielhaber E & Virshup DM (2001) Casein kinase I: from obscurity to center stage. IUBMB Life 51, 73-78.
33. Dubois T, Rommel C, Howell S, Steinhussen U, Soneji Y, Morrice N, Moelling K & Aitken A (1997) 14-3-3 is phosphorylated by casein kinase I on residue 233. Phosphorylation at this site in vivo regulates Raf/14-3-3 interaction. J Biol Chem 272, 28882-28888.
34. Hamaguchi A, Suzuki E, Murayama K, Fujimura T, Hikita T, Iwabuchi K, Handa K, Withers DA, Masters SC, Fu H & Hakomori S (2003) Sphingosine-dependent protein kinase-1, directed to 14-3-3, is identified as the kinase domain of protein kinase C delta. J Biol Chem 278, 41557-41565.
35. Tsuruta F, Sunayama J, Mori Y, Hattori S, Shimizu S, Tsujimoto Y, Yoshioka K, Masuyama N & Gotoh Y (2004) JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J 23, 1889-1899.
36. Truong AB, Masters SC, Yang H & Fu H (2002) Role of the 14-3-3 C-terminal loop in ligand interaction. Proteins 49, 321-325.
37. Michaud NR, Fabian JR, Mathes KD & Morrison DK (1995) 14-3-3 is not essential for Raf-1 function: identification of Raf-1 proteins that are biologically activated in a 14-3-3- and Ras-independent manner. Mol Cell Biol 15, 3390-3397.
38. Maru Y, Afar DE, Witte ON & Shibuya M (1996) The dimerization property of glutathione S-transferase partially reactivates BCR-Abl lacking the oligomerization domain. J Biol Chem 271, 15353-15357.
39. Megidish T, Cooper J, Zhang L, Fu H & Hakomori S (1998) A novel sphingosine-dependent protein kinase (SDK1) specifically phosphorylates certain isoforms of 14-3-3 protein. J Biol Chem 273, 21834-21845.
40. Powell DW, Rane MJ, Chen Q, Singh S & McLeish KR (2002) Identification of 14-3-3zeta as a protein kinase B/Akt substrate. J Biol Chem 277, 21639-21642.
41. Dubois T, Howell S, Amess B, Kerai P, Learmonth M, Madrazo J, Chaudhri M, Rittinger K, Scarabel M, Soneji Y & Aitken A (1997) Structure and sites of phosphorylation of 14-3-3 protein: role in coordinating signal transduction pathways. J Protein Chem 16, 513-522.
42. Pozuelo Rubio M, Geraghty KM, Wong BH, Wood NT, Campbell DG, Morrice N & MacKintosh C (2004) 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation, and trafficking. Biochem J
43. Rena G, Bain J, Elliott M & Cohen P (2004) D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Report 5, 60-65.
44. Salomon AR, Ficarro SB, Brill LM, Brinker A, Phung QT, Ericson C, Sauer K, Brock A, Horn DM, Schultz PG & Peters EC (2003) Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc Natl Acad Sci USA 100, 443-448.
45. Chaudhri M, Scarabel M & Aitken A (2003) Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. Biochem Biophys Res Commun 300, 679-685.
46. Toker A, Sellers LA, Amess B, Patel Y, Harris A & Aitken A (1992) Multiple isoforms of a protein kinase C inhibitor (KCIP-1/14-3-3) from sheep brain. Amino acid sequence of phosphorylated forms. Eur J Biochem 206, 453-461.
47. Nielsen PJ (1991) Primary structure of a human protein kinase regulator protein. Biochim Biophys Acta 1088, 425-128.
48. Jones DH, Martin H, Madrazo J, Robinson KA, Nielsen P, Roseboom PH, Patel Y, Howell SA & Aitken A (1995) Expression and structural analysis of 14-3-3 proteins. J Mol Biol 245, 375-384.
49. Peters KL & Smithgall TE (1999) Tyrosine phosphorylation enhances the SH2 domain-binding activity of BCR and inhibits BCR interaction with 14-3-3 proteins. Cell Signal 11, 507-514.
50. Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R & Pawson T (1994) BCR-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J 13, 764-773.
51. Lozzio CB & Lozzio BB (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45, 321-334.
52. Jones DH, Ley S & Aitken A (1995) Isoforms of 14-3-3 protein can form homo- and heterodimers in vivo and in vitro: implications for function as adapter proteins. FEBS Lett 368, 55-58.
53. Roseboom PH, Weller JL, Babila T, Aitken A, Sellers LA, Moffett JR, Namboodiri MA & Klein DC (1994) Cloning and characterization of the epsilon and zeta isoforms of the 14-3-3 proteins. DNA Cell Biol 13, 629-640.
54. Martin H, Rostas J, Patel Y & Aitken A (1994) Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem 63, 2259-2265.